Phaseline

Companies › TrueLab Biopharmaceutical

TrueLab Biopharmaceutical: clinical trials, targets and expected readouts

2 active drug programs in 2 registered trials: 2 Phase 1; Other; next expected readout Mar 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
TL-001–Phase 1Healthy VolunteersMar 2027
TL-003–Phase 1Healthy VolunteerApr 2027

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT06867796TL-001Phase 1Healthy VolunteersOtherMar 2027
NCT07526519TL-003Phase 1Healthy VolunteerOtherApr 2027

Targets

No annotated target.

Companies with the same targets

–

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.